Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Cancer Res. 2009 Mar 10;69(7):3196–3204. doi: 10.1158/0008-5472.CAN-08-3358

Figure 4.

Figure 4

NOS inhibition restores osteoclast differentiation in CD47−/− cells. A, WT and CD47−/− macrophages were differentiated into osteoclast in the presence of 50 ng/mL M-CSF and 50 ng/mL RANKL. RNA was isolated at days 1, 5, and 7, and cDNA was made. qPCR analysis was carried out with specific primers to iNOS. B, WT and CD47−/− macrophages were differentiated into osteoclasts in the presence of M-CSF, RANKL, and L-NAME, a pan-inhibitor of NOS, for 5 d.

HHS Vulnerability Disclosure